Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $60.0 million.

  • SOPHiA GENETICS's Non-Current Assets fell 70.53% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year decrease of 70.53%. This contributed to the annual value of $55.9 million for FY2024, which is 379.46% down from last year.
  • SOPHiA GENETICS's Non-Current Assets amounted to $60.0 million in Q3 2025, which was down 70.53% from $60.6 million recorded in Q2 2025.
  • SOPHiA GENETICS's 5-year Non-Current Assets high stood at $60.6 million for Q2 2025, and its period low was $23.8 million during Q2 2021.
  • For the 5-year period, SOPHiA GENETICS's Non-Current Assets averaged around $49.2 million, with its median value being $53.7 million (2023).
  • In the last 5 years, SOPHiA GENETICS's Non-Current Assets surged by 7913.09% in 2022 and then tumbled by 379.46% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Non-Current Assets stood at $37.3 million in 2021, then increased by 27.51% to $47.6 million in 2022, then rose by 22.12% to $58.1 million in 2023, then dropped by 3.79% to $55.9 million in 2024, then rose by 7.29% to $60.0 million in 2025.
  • Its Non-Current Assets was $60.0 million in Q3 2025, compared to $60.6 million in Q2 2025 and $56.7 million in Q1 2025.